spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 5 Nov 2015
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Nov 2015
Insys Therapeutics Announces Senior Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2015
Vaccinogen Promotes Peter Morsing, Ph.D. to Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Nov 2015
Flagship Ventures Launches Evelo Therapeutics To Develop Microbiome Therapies for Cancer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 4 Nov 2015
Allergan Enters Into Licensing Agreement with Mimetogen Pharmaceuticals to Develop and Commercialize Tavilermide (MIM-D3) Topical Dry Eye Treatment
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 3 Nov 2015
Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 3 Nov 2015
Solid GT Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Nov 2015
Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Nov 2015
CureVac raises $110 Million in a private placement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2015
Mallinckrodt's INOmax(R) Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Oct 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Approved by the European Commission as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Oct 2015
Pfizer Announcement Regarding Allergan plc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2015
BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 29 Oct 2015
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Oct 2015
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Oct 2015
Mirna Therapeutics Appoints Dr. Miguel Barbosa as Executive Vice President and Chief Scientific Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 26 Oct 2015
Recro Pharma Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 26 Oct 2015
U.S. FDA Approves BELBUCA(TM) (buprenorphine) Buccal Film for Chronic Pain Management
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Oct 2015
NeuroVive Strengthens Clinical Development Team With Appointment of Dr. Magnus Hansson as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Oct 2015
Spectrum Pharmaceuticals Receives Complete Response Letter (CRL) from U.S. Food and Drug Administration (FDA) for EVOMELA(TM) (melphalan) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Oct 2015
Merrimack Announces U.S. FDA Approval of ONIVYDE(TM) (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Oct 2015
Eiger BioPharmaceuticals Appoints Thomas J. Dietz, Ph.D. to the Eiger Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2015
Vtesse, Inc. Expands Scientific Advisory Board and Appoints New VP of Clinical Operations to Support Late-Stage Clinical Study of Lead Drug Candidate VTS-270
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Oct 2015
Allegro Ophthalmics Names Scott Cooper as Chief Financial Officer and Vice President of Business Development and Mohamed Genead, MD, as Executive Medical Director
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 21 Oct 2015
Unum Therapeutics Expands Leadership Team by Appointing Dr. Michael J. Vasconcelles as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Oct 2015
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Oct 2015
CMC Biologics Announces Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2015
Wilson Therapeutics Appoints Andrew Kay as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2015
Sorrento Expands its Executive Management Team with Appointment of Dr. Jeffrey Su as Chief Operating Officer to Lead its in-house Bioprocess and Manufacturing Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2015
Virttu Biologics Announces Appointment Of Deirdre Y. Gillespie As Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Oct 2015
Daiichi Sankyo, Inc. Reorganizes its U.S. Commercial Operations to Support Upcoming Specialty Pipeline
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2015
Eli Lilly and Company Expands New York City Research and Development Site
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2015
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Biopharmaceuticals
 HSMN NewsFeed - 15 Oct 2015
Bristol-Myers Squibb Appoints Paul Biondi Senior Vice President, Head of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Oct 2015
Biothera Appoints Dr. Jose Iglesias as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2015
Ovid Therapeutics Announces Appointment of Dr. Anna Kazanchyan to Senior Vice President, Business Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Oct 2015
Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Oct 2015
Impel NeuroPharma Closes First Tranche of Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 14 Oct 2015
Jzaneen Lalani Joins Curemark as Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Oct 2015
Viamet Appoints Dr. Oren Cohen as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Oct 2015
Galera Therapeutics Raises $37 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 14 Oct 2015
Kura Oncology Appoints Thomas Malley to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 13 Oct 2015
Timothy P. Walbert Joins Sucampo's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2015
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
Biopharmaceuticals Urology Generics Product Launch
 HSMN NewsFeed - 12 Oct 2015
Fate Therapeutics Announces Leadership Transition
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2015
Heron Therapeutics Appoints Neil J. Clendeninn, M.D., Ph.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
BioBlast Pharma Augments Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
Biogen Announces Departure of Tony Kingsley
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Oct 2015
Adheron Therapeutics to be acquired by Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Oct 2015
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Oct 2015
Novan Appoints Chief Financial Officer and Chief Commercial Officer to Leadership Team
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 7 Oct 2015
Quartet Medicine Completes $23.25 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 6 Oct 2015
Exelixis Announces Positive Overall Survival Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma
Biopharmaceuticals Oncology Dermatology
 HSMN NewsFeed - 5 Oct 2015
Otonomy Receives FDA Clearance of Investigational New Drug Application for Tinnitus Product Candidate, OTO-311
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2015
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 1 Oct 2015
AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Oct 2015
Bristol-Myers Squibb Receives Approval from the U.S. Food and Drug Administration for the Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen in BRAF V600 Wild-Type Unresectable or Metastatic Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2015
BioMarin to Acquire Rights to Phenylketonuria (PKU) Franchise From Merck Serono
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 30 Sep 2015
Tunitas Therapeutics Closes $10 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Sep 2015
Blueprint Medicines Receives FDA Orphan Drug Designation for Novel Drug Candidate for Treatment of Hepatocellular Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Sep 2015
Precision NanoSystems Raises $13.4M in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Sep 2015
Corvus Pharmaceuticals Completes $75 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2015
Zafgen Announces Transition of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2015
Teva Announces Approval of COPAXONE(R) in Japan for the Prevention of Relapse of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 28 Sep 2015
AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) Receives Approval in Japan for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Sep 2015
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in the European Union
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Sep 2015
Celgene’s VIDAZA(R) (Azacitidine for Injection) Receives Positive CHMP Opinion as New Treatment for Elderly Patients with Acute Myeloid Leukaemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Sep 2015
EU Marketing Approval Granted for VivaGel(R) BV
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Sep 2015
Cerulean Appoints David R. Walt, Ph.D. to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Sep 2015
Replimune Ltd Raises $30 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 Sep 2015
Pfizer’s Sayana(R) Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 22 Sep 2015
OticPharma Announces Key Additions to the Senior Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2015
CASI Pharmaceuticals to Raise $25.1 Million in Private Placement of Common Stock and Warrants
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 Sep 2015
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 18 Sep 2015
Momenta Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 18 Sep 2015
Infinity Expands Pipeline with Addition of IPI-549, an Immuno-Oncology Development Candidate for the Treatment of Solid Tumors
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 18 Sep 2015
Mylan Launches One of First Generic Lescol XL(R) Tablets
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2015
Espero Pharmaceuticals Announces Exclusive Licensing and Distribution Agreement
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 16 Sep 2015
Tokai Pharmaceuticals Augments Commercialization Capabilities through Appointment of Lisa Taylor as Senior Vice President, Commercial Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2015
David Kaysen Named President & CEO of Sun BioPharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2015
Marathon Pharmaceuticals Names Dr. Jordan Dubow Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2015
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Sep 2015
Jounce Therapeutics Appoints Kim Drapkin, CPA as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Sep 2015
Makindus Bolsters Management Team with Appointment of Michael Celano as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 14 Sep 2015
Mylan Commences Offer to Acquire Perrigo
Biopharmaceuticals Generic Mergers & Acquisitions
 HSMN NewsFeed - 14 Sep 2015
VBI Vaccines Promotes Dr. David E. Anderson to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2015
POZEN Appoints James P. Tursi, M.D. Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2015
Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha(TM) (Evolocumab)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Sep 2015
Akebia Therapeutics Announces Additions to its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2015
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Dermatology FDA
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!